Statins are FDA‐approved drugs prescribed to millions of people worldwide for the treatment of hypercholesterolemia and are used in preclinical studies to modulate CAV1 protein levels.[6, 13, 42] Even though statins‐targeted CAV1 is not specific, these studies have demonstrated that statins are potent inhibitors of CAV1. The gene discussed is CAV1; the disease is Hypercholesterolemia.